Bevacizumab plus low-dose metronomic oral cyclophosphamide in heavily pretreated recurrent ovarian cancer. Background: Neoadjuvant chemotherapy, compared to primary surgery, may be associated with ...
An open, multicenter clinical study on cetuximab combined with intensity modulated radiotherapy (IMRT) plus concurrent chemotherapy in nasopharyngeal carcinoma (NPC): Preliminary report. Functional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback